Candel Therapeutics (CADL)
(Real Time Quote from BATS)
$6.12 USD
-0.05 (-0.81%)
Updated Aug 6, 2025 10:12 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CADL 6.12 -0.05(-0.81%)
Will CADL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CADL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CADL
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know
Does Candel Therapeutics (CADL) Have the Potential to Rally 285.32% as Wall Street Analysts Expect?
CADL: What are Zacks experts saying now?
Zacks Private Portfolio Services
CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer
Best Momentum Stocks to Buy for May 19th
New Strong Buy Stocks for May 19th
Other News for CADL
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference | CADL ...
Candel Therapeutics (CADL) Secures EMA Orphan Status for Pancreatic Cancer Treatment | CADL ...
Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of ...
Candel Therapeutics receives EMA Orphan Designation for CAN-2409
ASML, J B Hunt Transport And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session